Beacon Angels

Founded 2/2006, Beacon Angels, a Boston-based angel group, celebrated a significant exit in the sale of SmartCells to Merck in December 2010. Members conduct due diligence and invest in early stage companies that demonstrate (1) strong third party buy-in, (2) protected technology and (3) a clear exit strategy. Submit executive summaries through www.beaconangels.com. Referred plans only please. Beacon Angels is a Boston-based angel group that makes investments in the $100,000 to $300,000 range in small fast-growing companies. Beacon Angels members attract and access a steady flow of early-stage private investment opportunities, and build portfolio value through shared capital, experience, and strategic relationships. Please see www.beaconangels.com to learn about joining.